Michelle Robertson - Aug 9, 2021 Form 4 Insider Report for Editas Medicine, Inc. (EDIT)

Role
Chief Financial Officer
Signature
/s/ Michelle Robertson
Stock symbol
EDIT
Transactions as of
Aug 9, 2021
Transactions value $
-$73,375
Form type
4
Date filed
8/10/2021, 04:33 PM
Previous filing
Jun 30, 2021
Next filing
Nov 17, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EDIT Common Stock Options Exercise $76.6K +2.5K +8.7% $30.65 31.2K Aug 9, 2021 Direct F1
transaction EDIT Common Stock Sale -$150K -2.5K -8% $60.00* 28.7K Aug 9, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EDIT Stock Option (right to buy) Options Exercise $0 -2.5K -2.13% $0.00 115K Aug 9, 2021 Common Stock 2.5K $30.65 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The exercise and sale reported in this Form 4 was effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 12, 2021.
F2 This option was granted on January 9, 2020 and is scheduled to vest over four years, with 25% of the shares having vested on January 9, 2021, and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through January 9, 2024.